ANGELA SHEEHAN: Open Payments
NPI 1710318381 · RENSSELAER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,166 in 38 payments from 6 companies in 2025. Trend: 2023 $1,299 · 2024 $520 · 2025 $1,166
Food & beverage: $1,166
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 17 | $420 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $288 |
| Janssen Pharmaceuticals, Inc | 4 | $267 |
| Otsuka America Pharmaceutical, Inc. | 2 | $146 |
| ABBVIE INC. | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
Products named: FANAPT, CAPLYTA, REXULTI, SPRAVATO, INVEGA SUSTENNA, VRAYLAR, Qelbree.
Industry payments across NY — which companies pay providers there.
